News By Tag
News By Place
BBI Solutions are supporting EQA Schemes in pursuit of accurate diagnostic results
In a drive to support accurate results within the in-vitro diagnostics (IVD) industry, BBI Solutions are offering a 10% discount across their product range for all external quality assessment (EQA) schemes.
To manufacture these control samples, EQA schemes require blood based biological materials, for example Hepatitis B positive human serum, or human plasma with elevated levels of thyroid peroxidase antibodies. BBI Solutions operate direct collection facilities in multiple countries to support the IVD industry with these essential raw materials.
Ensuring that results for disease diagnosis and management are always accurate runs parallel to the BBI Group vision - ‘a world where everyone has the opportunity for a better quality of life.’ To support the work that EQA Schemes undertake to achieve this, BBI Solutions are offering a 10% discount to help support and create awareness of this essential group within the IVD Industry.
BBI Solutions is a leading manufacturer of raw materials and finished test platforms for the in-vitro diagnostics and pharmaceutical markets. Founded in 1986 by John Chandler of Cardiff University, BBI has grown from a small specialist company to a global business with manufacturing sites spanning four countries.
Our range of raw materials includes human antigens, antibodies, serum and plasma products and clinical chemistry enzymes. We manufacture world renowned labels for lateral flow, ELISA assay and biosensors, including our gold nanoparticles and glucose oxidase.
BBI Solutions offer contract development and manufacturing services with a core focus on gold conjugation and lateral flow test manufacture
BBI Solutions is part of the BBI Group.